NEW YORK, May 4, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Relmada Therapeutics, Inc. (“Relmada” or the “Company”) (NYSE: RLMD) concerning possible violations of federal securities laws. Before market opened on October 13, 2022, Relmada announced the results of its RELIANCE III…Read More
RLMD Levi Korsinsky LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Relmada Therapeutics Inc MarketScreener
